Solutions
Online Inquiry
Global Services

Artificial T Cell Stimulator Development Services

Online Inquiry

The Importance of Artificial T Cell Stimulator

Adoptive cell therapies (ACT) using genetically engineered T cells with specific TCRs or CARs show promise in treating various cancers. However, relapse and limited remission duration remain challenges. The success of ACT depends on the T cells' ability to effectively recognize and eliminate tumor cells, which requires sufficient activation and proliferation. Artificial T cell stimulators play a crucial role by providing sustained stimulation, enhancing T cell expansion, and ultimately improving the overall efficacy and durability of ACT.

Advantages of Artificial T Cell Stimulator

  • Precise Control: Artificial T cell stimulators allow for precise control over the antigens presented to T cells. This enables targeting of specific immune responses and minimizing off-target effects.
  • Standardization and Reproducibility: Artificial T cell stimulators may be made consistently, resulting in repeatable outcomes and reducing batch-to-batch variability.
  • Versatility: Artificial T cell stimulators can be designed to target various T cell subsets as well as adapted for different applications.
  • Off-the-Shelf Availability: In contrast to using patient-derived APCs, Artificial T cell stimulators can be produced as off-the-shelf reagents, potentially simplifying and accelerating the development of cell-based immunotherapies.
  • Safety: Artificial T cell stimulators can potentially reduce the risk of infection and graft-versus-host disease associated with some cell-based therapies by eliminating the need for patient-derived cells.

Fig.1 Signals on aAPC to meet the therapeutic needs of adoptive T cells.Fig.1 Artificial T cell stimulating signals to satisfy adoptive T cell therapy requirements.1

Artificial T Cell Stimulator Development Services at Creative Biolabs

Creative Biolabs offers a range of artificial T cell stimulator development services for global customers to aid in developing and improving T cell therapies. To mimic the function of natural antigen-presenting cells, we intend to engineer non-APCs to express key signaling molecules that activate T cells, including MHC molecules, co-stimulatory molecules, adhesion molecules, etc. Our service encompasses a full range of services from artificial T cell stimulator design to functional validation. We can not only customize unique artificial T cell stimulators based on specific antigens or targeted T cell subsets but also flexibly produce them on a large scale according to customers' demand. Throughout the process, we employ stringent quality assurance techniques to ensure the functionality, stability, and safety of artificial T cell stimulators. Based on our robust platforms, we are confident in rapid results delivery for each of you.

In addition, we have developed different services based on different signal molecules or biomaterials, including:

Target T Cell Subsets

  • CD4+ helper T cells (Th1, Th2, Th17, Tfh, Tregs)
  • CD8+ cytotoxic T cells

Featured Advantages

Expertise

Experienced scientists' team with expertise in immunology, materials science, and bioengineering.

Cutting-edge technology

Access to advanced technologies for artificial T cell stimulator design, production, and characterization.

Customized solutions

Customized approaches to specific research and clinical requirements.

High-quality results

Consistent production of high-quality artificial T cell stimulators with defined characteristics.

Creative Biolabs has been heavily involved in the field of T cells for many years, with a strong theoretical background and extensive practical expertise. If you want to customize and develop a high-quality artificial T cell stimulator that meets your requirements, please contact us for more details.

Reference

  1. Li, Jing, Weilin Zhou, and Wei Wang. "Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells." Cellular and Molecular Life Sciences 81.1 (2024): 378. Distributed under Open Access License CC BY 4.0, without modification.
Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.